Alimera Sciences Inc expected to post a loss of 42  cents a share - Earnings Preview

Alimera Sciences

18/02/2022 16:21

* Alimera Sciences Inc  ALIM.OQ   ALIM.O  is expected
to show a
fall in quarterly revenue when it reports  results on February
24. 
    * The Alpharetta Georgia-based  company is expected to
report  a
2.7% decrease in revenue to $13.405 million from $13.77 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Alimera Sciences
Inc is
for a loss of 42 cents per share. For the same quarter last
year, the company reported a loss of 18 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Alimera
Sciences
Inc is $14.5​, about 67% above​ its last closing price
of $4.79. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.52       -0.52      -0.60     Missed  -14.3
 Jun. 30 2021  1.05        1.06       0.72      Missed  -32.1
 Mar. 31 2021  -0.52       -0.54      -0.63     Missed  -16.7​
 Dec. 31 2020  -0.04       -0.04      -0.18     Missed  -315.4
 ​​Sep.        -0.44       -0.44      -0.12     Beat    72.9
 30 2020                                                
 Jun. 30 2020  -1.09       -1.61      -0.51     Beat    68.4​
 Mar. 31 2020  -0.44       -0.43      -0.24     Beat    44.5
 Dec. 31 2019  -0.35       -0.45      0.08      Beat    117.7
 This summary was machine generated February 18 at 16:21 GMT. 
All figures in US dollars  unless otherwise stated